Literature DB >> 21160791

Future of bioartificial liver support.

Robert Afm Chamuleau1.   

Abstract

Many different artificial liver support systems (biological and non-biological) have been developed, tested pre-clinically and some have been applied in clinical trials. Based on theoretical considerations a biological artificial liver (BAL) should be preferred above the non-biological ones. However, clinical application of the BAL is still experimental. Here we try to analyze which hurdles have to be taken before the BAL will become standard equipment in the intensive care unit for patients with acute liver failure or acute deterioration of chronic liver disease.

Entities:  

Keywords:  Acute liver failure; Bioartificial liver; Cell transplantation; Liver transplantation; Tissue engineering; Xenotransplantation

Year:  2009        PMID: 21160791      PMCID: PMC2999112          DOI: 10.4240/wjgs.v1.i1.21

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  49 in total

1.  Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway.

Authors:  Philip N Newsome; John Tsiaoussis; Steven Masson; Robert Buttery; Cameron Livingston; Ian Ansell; James A Ross; Tariq Sethi; Peter C Hayes; John N Plevris
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

Review 2.  Hepatic tissue engineering for adjunct and temporary liver support: critical technologies.

Authors:  Christina Chan; François Berthiaume; Bharath D Nath; Arno W Tilles; Mehmet Toner; Martin L Yarmush
Journal:  Liver Transpl       Date:  2004-11       Impact factor: 5.799

3.  Assessment of the AMC-bioartificial liver in the anhepatic pig.

Authors:  Meindert N Sosef; Leo S L Abrahamse; Maarten-Paul van de Kerkhove; Robin Hartman; Rob A F M Chamuleau; Thomas M van Gulik
Journal:  Transplantation       Date:  2002-01-27       Impact factor: 4.939

4.  Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure.

Authors:  T M Khalili; A Navarro; P Ting; Y Kamohara; N Arkadopoulos; B A Solomon; A A Demetriou; J Rozga
Journal:  Artif Organs       Date:  2001-07       Impact factor: 3.094

5.  Personal view: current role of artificial liver support devices.

Authors:  J O'Grady
Journal:  Aliment Pharmacol Ther       Date:  2006-06-01       Impact factor: 8.171

6.  Biologic liver support: optimal cell source and mass.

Authors:  E Morsiani; M Brogli; D Galavotti; P Pazzi; A C Puviani; G F Azzena
Journal:  Int J Artif Organs       Date:  2002-10       Impact factor: 1.595

Review 7.  Acute liver failure: liver support therapies.

Authors:  Vanessa Stadlbauer; Rajiv Jalan
Journal:  Curr Opin Crit Care       Date:  2007-04       Impact factor: 3.687

8.  The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model.

Authors:  Shin Enosawa; Tomoyuki Miyashita; Tomohiro Saito; Takeshi Omasa; Toshiharu Matsumura
Journal:  Cell Transplant       Date:  2006       Impact factor: 4.064

Review 9.  A bioartificial liver--state of the art.

Authors:  Alastair J Strain; James M Neuberger
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

10.  Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.

Authors:  L M Flendrig; R A Chamuleau; M A Maas; J Daalhuisen; B Hasset; C G Kilty; S Doyle; N C Ladiges; G G Jörning; J W la Soe; D Sommeijer; A A te Velde
Journal:  J Hepatol       Date:  1999-02       Impact factor: 25.083

View more
  4 in total

1.  Influence of 3D porous galactose containing PVA/gelatin hydrogel scaffolds on three-dimensional spheroidal morphology of hepatocytes.

Authors:  Kirthanashri S Vasanthan; Anuradha Subramaniam; Uma Maheswari Krishnan; Swaminathan Sethuraman
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

Review 2.  Progress of key strategies in development of electrospun scaffolds: bone tissue.

Authors:  Sumit Pramanik; Belinda Pingguan-Murphy; Noor Azuan Abu Osman
Journal:  Sci Technol Adv Mater       Date:  2012-08-08       Impact factor: 8.090

Review 3.  Stem cell differentiation and human liver disease.

Authors:  Wen-Li Zhou; Claire N Medine; Liang Zhu; David C Hay
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

4.  Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study.

Authors:  Pengcheng Zhou; Li Shao; Lifu Zhao; Guoliang Lv; Xiaoping Pan; Anye Zhang; Jianzhou Li; Ning Zhou; Deying Chen; Lanjuan Li
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.